Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.
about
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesStem cell-based regenerative opportunities for the liver: State of the art and beyondAdvances in hepatic stem/progenitor cell biologyIn Vitro and In Vivo Hepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver DiseasesHuman adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applicationsThe Regenerative Role of the Fetal and Adult Stem Cell SecretomeHuman bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury.Extracellular Vesicles from Bone Marrow-Derived Mesenchymal Stem Cells Improve Survival from Lethal Hepatic Failure in Mice.Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury.Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regenerationMesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models.Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.The structural and functional recovery of pancreatic β-cells in type 1 diabetes mellitus induced mesenchymal stem cell-conditioned medium.Mesenchymal stem cell-derived hepatocytes for functional liver replacement.Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling PathwayAF-MSCs fate can be regulated by culture conditionsSox2 suppression by miR-21 governs human mesenchymal stem cell properties.Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.Placental amniotic epithelial cells and their therapeutic potential in liver diseases.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.IL - 10 secreted by Mesenchymal stem cells attenuates acute liver failure through inhibiting pyroptosis.Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells.Progress in stem cell-based therapy for liver disease.Effect of Secreted Molecules of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells on Acute Hepatic Failure Model.Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells.Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation.Prospect of stem cell conditioned medium in regenerative medicine.Amniotic fluid and amniotic membrane stem cells: marker discovery.Hypoxia Pre-Conditioned Embryonic Mesenchymal Stem Cell Secretome Reduces IL-10 Production by Peripheral Blood Mononuclear Cells.Rodent animal models for surrogate analysis of cell therapy in acute liver failureTherapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure.Isolation and Molecular Characterization of Amniotic Fluid-Derived Mesenchymal Stem Cells Obtained from Caesarean Sections.Role of Human Wharton's Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d-Galactosamine Induced Acute Liver Injury in Mice.Eminent Sources of Adult Mesenchymal Stem Cells and Their Therapeutic Imminence.Comparative study between amniotic-fluid mesenchymal stem cells and retinal pigmented epithelium (RPE) stem cells ability to differentiate towards RPE cells.Three-dimensional spheroid culture of human umbilical cord mesenchymal stem cells promotes cell yield and stemness maintenance.Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.Cartilage Regeneration in Humans with Adipose Tissue-Derived Stem Cells and Adipose Stromal Vascular Fraction Cells: Updated StatusAmniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
P2860
Q26750573-156938BC-FBC7-41A8-AAB6-649F7454C108Q26775924-FFB63238-BF5D-4DE0-9611-EB9385BC918EQ26776305-FE1766BD-AC33-4D35-A6A5-3741BEB9606CQ26782994-DF51FC46-D1E1-4FFC-9403-3C6399867072Q26998695-873BCE5D-AAA6-4A88-8633-21DA136C4B3FQ27004398-1FAAD02D-13B2-4DB5-81DD-E261516513C3Q33580844-FFA2BAB0-3317-4670-959D-A7B78E5FC31CQ33722644-50F98EA0-BA4A-42AA-82FB-4E34CE727D07Q34334408-9D42FBEE-0724-419A-988F-CD301EB3B838Q34405145-C246A234-F979-46AE-8236-140E1EEEBF31Q34500223-16E9D59B-6E37-496F-82B5-2046972CE688Q34566545-669A7F71-A184-4895-AD19-AF79A2214147Q35196706-2C17A2D3-D911-4E5E-846F-84115075021DQ36047818-67075DF1-8AB6-43C6-8B23-3E34E11918DEQ36052620-EE49A4A1-1AD4-4420-9702-94F36521CE7AQ36797833-279BE0B1-90E8-4B46-BD8D-431919D5B35AQ36890227-C74265AC-7FD1-4BB2-93C4-F916F2167E3FQ37516478-9A74D980-BA00-4838-BB38-0086865940D8Q38198125-1495736B-4AB8-4F82-9D16-13FE19E338BDQ38320451-BC20200C-B16D-4809-B4E8-CCAC9F2BB700Q38608414-A16CEC1E-2943-4C9C-A40F-D641C132A38BQ38611853-86BFBCAE-AB1A-4184-A74D-2804CD77EF38Q38816893-74634627-5C93-4457-8555-2F06BAB3A7BDQ38836460-DDD76D85-A262-43C3-BF9D-BEA754CC736EQ39347132-7D0EBDDA-BDC5-4424-B9CD-2921D364EAF4Q39501841-B042AF63-CD22-4A79-919C-774B64494A79Q41412535-D0D5310B-4C28-4E18-91BA-8385E81B958FQ41660528-4C8BDBB3-0CE0-4295-A334-43F7DDC65BDDQ42196647-A1C513F3-B77F-4AA6-BDB9-A3226CFACD9BQ42242902-8D982703-0F37-416D-9AFD-CAF108FAA0F6Q42556938-82F4B1F0-3FB0-4E03-92E2-1EBE37E6965EQ44414964-8D887FCA-58EB-4CBF-B16D-9F4A9D2BB99AQ47155992-C765C411-46AC-43BC-8016-3DE31B0CFF72Q47751965-A7CD54EA-CE1A-4C95-92A7-2DE61A4B3CC4Q47790688-1719FB3E-161B-401F-8496-6BC31BC8F6E9Q50983893-315A03AF-671A-47CF-B4FC-80D3B8AB6162Q51000940-2EE16D71-7536-4CC3-A793-326D0882AE43Q51210577-9AA906C7-DC42-4FA6-BF49-C873DD579D99Q56523225-00E9959B-0AB9-47F2-BF7D-FE0FAF5A88C6Q57153004-6AA71EDC-04DF-4F60-AF14-7D0E5A5F4CE0
P2860
Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@en
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@nl
type
label
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@en
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@nl
prefLabel
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@en
Therapeutic potential of a dis ...... ce with acute hepatic failure.
@nl
P2093
P50
P1433
P1476
Therapeutic potential of a dis ...... ice with acute hepatic failure
@en
P2093
Aristidis Antsaklis
Dimitra S Zagoura
Kalliopi I Pappa
Nicholas P Anagnou
Vasiliki Bitsika
P304
P356
10.1136/GUTJNL-2011-300908
P407
P577
2011-10-13T00:00:00Z